未登录

N

Nikolaos Kokras

National and Kapodistrian University of Athens

H指数:32

被引数:3,801

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Models of depression for preclinical drug discovery and development: an update of the literature

抑郁症模型用于临床前药物发现与开发：文献更新

Expert Opinion on Drug Discovery

IF4.9

2026-08-190

PRE

Pharmacokinetics and pharmacodynamics: making clinical sense of sex differences in psychopharmacology

Expert Opinion on Drug Metabolism & Toxicology

IF3.4

2026-02-060

PRE

Investigating the effect of chronic stress, depressive-like pathology and cognitive impairments on acute myocardial infarction: sex-differentiated effects

EUROPEAN HEART JOURNAL

IF35.6

2024-10-280

PRE

A case of delirium following treatment with low dose mirtazapine and pregabalin

EUROPEAN PSYCHIATRY

IF6.7

2024-08-270

OAAI

Prefrontal cortex-nucleus reuniens-hippocampus network exhibits sex-differentiated responses to stress and antidepressant treatment in rats

PSYCHOPHARMACOLOGY

IF3.3

2024-08-203

PRE

Drug-drug interactions between COVID-19 drug therapies and antidepressants

新型冠状病毒肺炎药物疗法与抗抑郁药之间的药物相互作用

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY

IF3.4

2023-11-303

PRE

A systematic review and meta-analysis on the effect of selective serotonin reuptake inhibitors on endothelial function

JOURNAL OF AFFECTIVE DISORDERS

IF4.9

2022-11-019

PRE

Imperatorin Influences Depressive-like Behaviors: A Preclinical Study on Behavioral and Neurochemical Sex Differences

IF4.6

2022-02-106

OAAI

Off-Target Effects of Antidepressants on Vascular Function and Structure

IF3.9

2021-12-285

OAAI

Sex differences in anxiolytic and antidepressant response following subacute drug treatment: the effect of the oestrous cycle

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2021-12-010

PREAI

Implications of sex-related differences in central nervous system disorders for drug research and development

NATURE REVIEWS DRUG DISCOVERY

IF101.8

2021-07-0516

PREAI

Differences in cause and 12-month follow-up outcome of parkinsonian symptoms in depressed older adults treated with antipsychotics: a case series

IF3.6

2021-06-030

OAAI

Antidepressants' effects on testosterone and estrogens: What do we know?

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2021-05-0139

PREAI

Detrimental effects of adolescent escalating low-dose Δ9-tetrahydrocannabinol leads to a specific bio-behavioural profile in adult male rats

BRITISH JOURNAL OF PHARMACOLOGY

IF7.7

2021-02-2718

OAAI

Innovative screening models for the discovery of new schizophrenia drug therapies: an integrated approach

EXPERT OPINION ON DRUG DISCOVERY

IF4.9

2021-01-2910

PREAI

Behavioral and Neurochemical Effects of Extra Virgin Olive Oil Total Phenolic Content and Sideritis Extract in Female Mice

IF4.6

2020-10-289

OAAI

Psychoactive properties of BNN27, a novel neurosteroid derivate, in male and female rats

PSYCHOPHARMACOLOGY

IF3.3

2020-06-0713

PREAI

Allosteric modulation of AMPA receptors counteracts Tau-related excitotoxic synaptic signaling and memory deficits in stress- and Aβ-evoked hippocampal pathology

MOLECULAR PSYCHIATRY

IF10.1

2020-05-2812

PREAI

Sex differences in experimental studies of depression: How can clinical research benefit?

EUROPEAN PSYCHIATRY

IF6.7

2020-03-230

PREAI

The therapeutic potential of natural compounds against Alzheimer's disease: A preclinical pharmacological study in both sexes

EUROPEAN PSYCHIATRY

IF6.7

2020-03-230

OAAI